Aristeia Capital’s Omnicell OMCL Stock Holding History

Aristeia Capital’s Portfolio OMCL Stock Details OMCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-33,400	Closed	-$2.49M	–	276
2020 Q3	$2.49M	Buy	+33,400	New	+$2.31M	0.1%	137

Other funds holding OMCL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Aristeia Capital's OMCL Position: Q4 2020 in Review

Aristeia Capital sold out of Omnicell (OMCL) in Q4 2020, closing a stake of 33,400 shares — an estimated $2.49M sold.

Aristeia Capital first reported a position in OMCL in Q3 2020 and held it in 1 quarter. The position peaked at $2.49M in Q3 2020. 354 funds tracked by Wall St. Rank hold OMCL as of Q4 2020.

Aristeia Capital reported no remaining Omnicell position as of Q4 2020 after selling out during the quarter.
Aristeia Capital sold 33,400 Omnicell shares in Q4 2020, an estimated $2.49M.
Aristeia Capital first reported a position in Omnicell in Q3 2020 and held it in 1 quarter.
Aristeia Capital's Omnicell position peaked at $2.49M in Q3 2020.
354 funds tracked by Wall St. Rank held Omnicell as of Q4 2020.

Based on Aristeia Capital's 13F filing for Q4 2020, filed 16 Feb 2021.